129 related articles for article (PubMed ID: 33435649)
1. Clinicopathological significance of epidermal growth factor receptor expression in papillary thyroid carcinoma: a meta-analysis.
Qin XR; Huang JK; Yin QF; Shi XM; Tang JC; Hao LL; Li PF; Zhu J; Wang YX
Minerva Endocrinol; 2021 Jan; ():. PubMed ID: 33435649
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis.
Wen J; Qin X; Zhang J; Wu X; Yan X; Lu K; Yang P; Ji S; Zhao X; Wang Y
World J Surg Oncol; 2023 Jul; 21(1):225. PubMed ID: 37496069
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis.
Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K
Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203
[TBL] [Abstract][Full Text] [Related]
4. A protective factor against lymph node metastasis of papillary thyroid cancer: Female gender.
Shi P; Yang D; Liu Y; Zhao Z; Song J; Shi H; Wu Y; Jing S
Auris Nasus Larynx; 2023 Jun; 50(3):440-449. PubMed ID: 36253315
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
6. Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma.
Zhou J; Li DX; Gao H; Su XL
World J Clin Cases; 2022 Apr; 10(12):3709-3719. PubMed ID: 35647144
[TBL] [Abstract][Full Text] [Related]
7. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
8. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Mao J; Zhang Q; Zhang H; Zheng K; Wang R; Wang G
Front Endocrinol (Lausanne); 2020; 11():265. PubMed ID: 32477264
[No Abstract] [Full Text] [Related]
10. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.
Zhang HS; Lee EK; Jung YS; Nam BH; Park B
Cancer Epidemiol; 2019 Dec; 63():101589. PubMed ID: 31494519
[TBL] [Abstract][Full Text] [Related]
11. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
Lin X; Su H; Huo J; Zhang F
Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
[TBL] [Abstract][Full Text] [Related]
12. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Li C; Lee KC; Schneider EB; Zeiger MA
J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H
Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400
[TBL] [Abstract][Full Text] [Related]
14. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
[TBL] [Abstract][Full Text] [Related]
15. EGFR and CXCR1 expression in thyroid carcinoma in Qassim Region-Saudi Arabia: Correlation with clinicopathological parameters.
Omran OM
Pathophysiology; 2019 Jun; 26(2):145-151. PubMed ID: 31031057
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic Features, Nodule Size, Capsular Invasion, and Lymph Node Metastasis of Solitary Papillary Carcinoma of Thyroid Isthmus.
Luo H; Yan F; Lan L; Ma B; Zhao H; He Y; Peng Y
Front Oncol; 2020; 10():558363. PubMed ID: 33117691
[No Abstract] [Full Text] [Related]
18. Predictive Value of BRAF
Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
[TBL] [Abstract][Full Text] [Related]
19. Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes?
Sulaieva O; Chernenko O; Chereshneva Y; Tsomartova D; Larin O
Pathophysiology; 2019 Jun; 26(2):129-135. PubMed ID: 31097263
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
Zhang X; Ni T; Zhang W
Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
